SANDOZ IRBESARTAN HCT
SANDOZ CANADA INCORPORATED
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of SANDOZ IRBESARTAN HCT in Canada?
Yes. SANDOZ IRBESARTAN HCT 12.5MG 150MG has an active shortage reported to Health Canada (last updated September 14, 2026).
Why is SANDOZ IRBESARTAN HCT not available?
The reason the manufacturer reported: Demand increase for the drug.
When will SANDOZ IRBESARTAN HCT be available again?
The manufacturer's estimated resolution date is October 16, 2026. This is an estimate and can change; follow this page to get an email when the status changes.
What this means
Does this mean my pharmacy is out of stock?
Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.
What should I do?
Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.
Estimated Resolution
2026-10-16
~18 days remaining (estimate)
This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.
DIN
02337428
Strength
12.5MG 150MG
Dosage Form
TABLET
Route
ORAL
Active Ingredient
HYDROCHLOROTHIAZIDE IRBESARTAN
Tier
Unrated
Last Updated
2026-09-14
Reason for Shortage
Demand increase for the drug.
Past Reports for This Drug
SANDOZ IRBESARTAN HCT has 2 shortage/discontinuation reports on file — this is one of them.
Other Products from SANDOZ CANADA INCORPORATED
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
200MG · DIN 02243098
5MG · DIN 02269198
500MCG · DIN 02248181
250MG · DIN 02242971
50MG · DIN 02242325
DIN 02495929
DIN 02495910
DIN 02495937
250MG · DIN 02246533
1MG · DIN 02548968
10MG · DIN 02513420
10MG · DIN 02236759